A blinded randomised controlled trial to determine the effect of enteric coating on enzyme treatment for canine exocrine pancreatic insufficiency

Table 2 Baseline characteristics of dogs on two different enzyme treatments for canine exocrine pancreatic insufficiency

Criterion	Test treatment (coated)	Control treatment (uncoated)	P value
Breed	Border collie (1), CKCS (1),	Akita (2), CKCS (1),	---
	Cocker spaniel (1),	Dogues de Bordeaux (1),
	GSD (12), Lhasa apso (1), mixed breed (2)	GSD (13), mixed breed (2)
	West Highland white terrier (1)	Tibetan terrier (1)
Sex	Male (8)	Male (5)	0.329
	Neutered male (4)	Neutered male (3)
	Female (2)	Female (7)
	Neutered female (5)	Neutered female (5)
Age (months)	41 (12 to 108)	48 (11 to 144)	0.829
Cobalamin¹	Hypocobalaminemic (5), normocobalaminemic (9),	Hypocobalaminemic (7), normocobalaminemic (9),	0.668
	Not measured (6)	Not measured (4)

The table reports signalment and cobalamin status in dogs, with exocrine pancreatic insufficiency, randomised to receive one of two enzyme treatments (test e.g. coated and control e.g. uncoated). Numerical data are expressed as median (range). CKCS: Cavalier King Charles Spaniel; GSD: German Shepherd Dog. ¹Given that various laboratories were used (with different reference ranges), cobalamin data expressed in categories (e.g. normcobalaminaemia, hypocobalaminaemia) rather than as absolute concentrations. There were no differences between groups for any of the baseline parameters.

ISSN: 1746-6148